Moderna in prime position to offer first combined flu/Covid shot
Covid-19 stock market darling Moderna (MRNA) appears to be getting its mojo back with investors following a punishing 85% drop in the shares from their September 2021 highs.Over the last six months Moderna's shares have more than...
13 June 2024
